Lupin Limited has informed the Exchange regarding a press release dated May 13, 2026, titled "Lupin Receives U.S. FDA Approval for Famotidine Injection, USP".
Lupin Limited has informed the Exchange regarding a press release dated May 13, 2026, titled "Lupin Receives U.S. FDA Approval for Famotidine Injection, USP".